Showing results (101-110 of 140) with videos related to
Sort By:
Pageof 14
Cancer Immunology, Immunotherapy : CII|July 12, 2025
Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomasJing Ma, Tina Sarén, Chuan Jin, et al.Nature Communications|February 20, 2016
YY1 inhibits differentiation and function of regulatory T cells by blocking Foxp3 expression and activitySoo Seok Hwang, Sung Woong Jang, Min Kyung Kim, et al.Oncology Letters|July 19, 2012
Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia associated with neuroendocrine carcinoma: A case reportHee Jun Kim, In Ho Moh, Hana Yoo, et al.Proceedings of the National Academy of Sciences of the United States of America|December 4, 2019
Homeobox protein Hhex negatively regulates Treg cells by inhibiting Foxp3 expression and functionSung Woong Jang, Soo Seok Hwang, Hyeong Su Kim, et al.Journal of Personalized Medicine|September 28, 2023
miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53Kyung-Jun Lee, Nitya Singh, Michael Bizuneh, et al.Cancer Chemotherapy and Pharmacology|January 30, 2015
A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancerDae Ro Choi, Sang Nam Yoon, Hyeong Su Kim, et al.Oncology Letters|December 4, 2012
Irinotecan, leucovorin and 5-fluorouracil (modified FOLFIRI) as salvage chemotherapy for frail or elderly patients with advanced gastric cancerJung Han Kim, Hyeong Su Kim, A Rum Han, et al.Medical Physics|May 8, 2012
Variations in dose distribution and optical properties of Gafchromic(TM) EBT2 film according to scanning modeSoah Park, Sei-Kwon Kang, Kwang-Ho Cheong, et al.Cancer Research and Treatment|October 25, 2013
A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer PatientsGeundoo Jang, Hun Ho Song, Keon Uk Park, et al.International Journal of Colorectal Disease|July 18, 2009
A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancerHyeong Su Kim, Min Jae Park, Ji Eun Uhm, et al.Pageof 14